Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare IT News
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Canada Welcomes Public Drug Plan Reimbursement by Alberta, Saskatchewan, Québec, Veteran Affairs Canada and the Non-Insured Health Benefits Program for Patients prescribed AJOVY® (fremanezumab) for the Preventive Treatment of Migraine in
TEVA PHARMACEUTICALS USA, INC: Teva Announces Updated Indication and Vial Presentation for GRANIX® (tbo-filgrastim) Injection in United States | American Pharmacy News
Teva Pharmaceutical Industries Limited Blog | Talkmarkets | Page 1
Outgoing Moderna CMO Lands Seat on Teva Pharmaceuticals Board of Directors | BioSpace
Teva CEO stands down during troubled times - MedCity News
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
Drug companies to pay $70 million for delaying cheaper generics, California AG says | Fox 59
Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug | Fierce Pharma
Teva's AJOVY® Receives EU Approval Offering Patients the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Prophylaxis of Migraine in Adults | Nasdaq
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva Announces New Organization Structure and Leadership Changes | Business Wire
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva pharmaceuticals Stock Photo - Alamy
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance at 8 a.m. ET on February 10, 2021 | Business Wire
News & Media
News & Media
Teva Pharmaceuticals (@TevaUSA) / Twitter
N.Y. jury holds drugmaker Teva liable in opioid crisis | The Sumter Item
New York jury holds drug firm Teva liable in opioid crisis
$225 Million Settlement Reached With Teva Pharmaceutical Industries Is Fourth Opioid Settlement For Texas - Ksst Radio
Bristol Myers Squibb's Revlimid finally faces competition in the U.S. with Teva's generic launch | Fierce Pharma
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva Unveils New Spring 2022 Collection
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire
